Our History

Alan Gold forms Goldstone Real Estate Finance and Investments and establishes the business model for institutional ownership of office and laboratory space for the life science industry.

Alan Gold and Gary Kreitzer serve as President and Senior Vice President/In-House Counsel, respectively, for Health Science Properties Trust which executes an initial public offering as Alexandria Real Estate Equities.

Alan Gold and Gary Kreitzer leave Alexandria Real Estate Equities and form Bernardo Property Advisors, Inc. to acquire and manage lab space properties for lease to the life science industry.

BioMed Realty Trust, Inc., a real estate investment trust (REIT), is formed out of Bernardo Property Advisors, Inc. and executes an initial public offering, trading on the New York Stock Exchange under the ticker symbol "BMR". Matthew McDevitt joins BioMed Realty as Vice President, Acquisitions.

Subsequent investments in life science properties in San Diego, San Francisco, Seattle, New York, Pennsylvania and Maryland, including The Landmark at Eastview in Tarrytown, New York.

A portfolio of seven life science properties in Cambridge, Massachusetts and one property in Lebanon, New Hampshire are acquired, with existing tenants including Genzyme Corporation and Vertex Pharmaceuticals.

Kent Griffin joins BioMed Realty as Chief Financial Officer.

Shady Grove Road in Rockville, Maryland, which serves as Human Genome Sciences' 635,000 square foot corporate headquarters and laboratory and manufacturing facilities, is acquired in a long-term sale-leaseback transaction, along with HGS' 290,000 square foot large scale manufacturing facility and adjacent undeveloped land which can support up to an estimated 500,000 rentable square feet of lab space and office facilities.

The Pacific Research Center campus in Newark, California is acquired. The property includes ten buildings comprising approximately 1.4 million square feet of office and lab space, as well as undeveloped land.

The Center for Life Science | Boston is acquired, 700,000+ square foot, state-of-the-art life science building under development at the time of purchase. Located in the heart of Boston's Longwood Medical area, CLSB is currently 99% leased on a long-term basis, with tenants including Beth Israel Deaconess Medical Center, Children's Hospital Boston, Dana-Farber Cancer Institute, Kowa Company and the Immune Disease Institute.

A joint venture is formed with Prudential Real Estate Investors (PREI®) to complete the acquisition of a portfolio of properties in Cambridge, Massachusetts, including approximately 600,000 square feet of life science space completed or under construction and land that can support approximately an estimated 266,000 square feet of life science laboratory and office space.

Novo Nordisk A/S signs new lease for approximately 36,900 square feet of office and lab space at the Fairview Research Center in Seattle.

Children's Hospital Boston, a pre-eminent pediatric research institution and teaching affiliate of the Harvard Medical School, signs an amendment to its lease at the Center for Life Science | Boston for an additional 49,000 square feet, bringing its total occupancy in the facility to over 150,000 square feet. Alan Gold, BioMed Realty's Chairman and Chief Executive Officer, receives the national Ernst & Young LLP Entrepreneur Of The Year® 2008 Award in the Real Estate, Construction and Hospitality category.

Kent Griffin is promoted to President and Chief Operating Officer of BioMed Realty.

Vertex Pharmaceuticals signs early extensions and renewals on two leases totaling in excess of 292,000 square feet of space through December 31, 2015 in Cambridge, Massachusetts, including its corporate headquarters. Kowa Company, one of Japan's largest privately owned companies and its fifth largest trading company, signs a new lease at the Center for Life Science | Boston for approximately 24,400 square feet of laboratory and office space. v

The Center for Life Science | Boston receives Gold LEED® certification.

In October, BioMed Realty and Regeneron Pharmaceuticals host a ribbon-cutting ceremony to celebrate the completion of Regeneron's new 229,000 square foot corporate headquarters and research facility developed by BioMed Realty at The Landmark at Eastview in Tarrytown, New York. In December, BioMed Realty enters into a new lease with Regeneron for an additional 131,000 square feet of newly-constructed laboratory and office space at The Landmark campus.

Strategic real estate partnership with Isis Pharmaceuticals expands with the groundbreaking on a 176,000 square foot build-to-suit research and development facility in Carlsbad, California. Greg Lubushkin is promoted to Chief Financial Officer.

BioMed Realty acquires a life science building at 3500 Paramount Parkway in Morrisville, North Carolina within the Research Triangle Park submarket of North Carolina. The building comprises approximately 61,600 square feet which is 100% leased to Bayer CropScience, a wholly owned subsidiary of Bayer AG.

BioMed Realty acquires two adjacent life science campuses in South San Francisco, California comprising approximately 489,000 square feet of rentable office, laboratory and industrial space. The Science Center at Oyster Point comprises two newly constructed facilities with an aggregate of approximately 205,000 square feet, which are 100% leased on a long-term basis to Elan Corporation. The Gateway Business Park is a research and development park comprised of six buildings with an aggregate of approximately 284,000 square feet, with development rights for an additional 946,000 square feet, which is fully leased to Elan Corporation, FedEx Corporation and Genentech, Inc., a member of the Roche Group.

Matthew McDevitt is promoted to Executive Vice President, Real Estate.

BioMed Realty acquires two properties comprised of seven fully-leased life science buildings and approximately 300,000 square feet located along the I-270 Corridor in Montgomery County, Maryland. Tenants include MedImmune, Inc., a wholly-owned subsidiary of AstraZenica PLC.

BioMed Realty receives investment grade corporate credit ratings from Standard & Poor's Rating Services and Moody's Investors Service.

Harvard University's Hansjorg Wyss Institute for Biologically Inspired Engineering and Pfizer's Center for Therapeutic Innovation sign new leases at the Center for Life Science | Boston.

Logitech, a world leader in personal computer navigation, Internet communications, digital music, home-entertainment control, gaming and wireless devices, signs a new lease at the Pacific Research Center in Newark, California for approximately 263,500 square feet of office space.

BioMed acquires Ardsley Park, a life science campus in Ardsley, New York, comprising approximately 160,500 square feet of laboratory and office space and 500,000 square feet of future redevelopment and development potential. Concurrently, the company signs a new lease with Acorda Therapeutics, Inc. at Ardsley Park for approximately 138,200 square feet of laboratory and office space.

BioMed Realty and Isis Pharmaceuticals celebrate the completion of Isis' new 176,000 square foot build-to-suit corporate headquarters and research facility developed by BioMed Realty at Gazelle Court in the Carlsbad Oaks North Business Park of Carlsbad, California. The state-of-the-art complex consolidates the majority of Isis' operations into a single facility.

BioMed Realty acquires PREI's® 80% interest in the Rogers Street properties. The company previously acquired a 20% interest in the properties in April 2007 concurrent with the joint venture entered into between BioMed Realty and PREI. The Rogers Street properties are located in the heart of the Cambridge life science community and include two laboratory and office facilities totaling over 600,000 rentable square feet at 301 Binney Street and 320 Bent Street, as well as the Kendall Crossing Apartments and the Binney Street Garage.

Omeros Corporation, a clinical-stage biopharmaceutical company, signs a new 15-year lease at the Waterfront Research Center in Seattle, Washington for approximately 64,500 square feet of laboratory and office space. BioMed Realty acquires Cambridge Place, comprising three buildings and a total of approximately 287,000 square feet of space in Cambridge, Massachusetts. In aggregate, the property is approximately 80% leased at acquisition.

Depomed, Inc., a specialty pharmaceutical company, signs a new lease at Pacific Research Center North on BioMed Realty's multi-tenant Pacific Research Center campus for approximately 60,000 square feet of laboratory and office space. Over the previous 18 months, BioMed Realty leased over 660,000 square feet of laboratory, office and manufacturing space at the Pacific Research Center, which includes Pacific Industrial Center, Pacific Research Center North and Pacific Research Center South.

BioMed Realty completes the acquisition of two parcels of land, comprising approximately 28 adjacent acres in San Diego, California and concurrently enters into a long-term ground lease for both sites with Shire Regenerative Medicine, a subsidiary of Shire plc., which develops, manufactures and commercializes living cell-based therapies. Shire intends to construct office, laboratory, warehouse and manufacturing facilities totaling in excess of 150,000 square feet on the site commencing in early 2013. The site can accommodate future expansion of up to a total of 800,000 square feet. BioMed Realty acquires Granta Park, comprising eleven laboratory and office buildings and a total of approximately 472,200 square feet of space, as well as approximately 138,400 square feet of development and expansion rights, in Cambridge, United Kingdom. Granta Park is fully leased at acquisition to a diversified roster of eleven tenants, including global pharmaceutical and biotechnology organizations, with an average remaining lease term of more than eight years. With this new investment, BioMed Realty expands current tenant relationships with MedImmune (and parent company AstraZeneca) and Pfizer, and establishes new relationships with Gilead Sciences, Pharmaceutical Product Development, UCB, and Vernalis.

BioMed Realty unveils a new brand identity that highlights its commitment to the life science industry by delivering state-of-the-art laboratories and office spaces to meet the unique needs of its tenants. The brand identity features an energetic new look comprised of a monogram logo in the stylized shape of the company's initials and NYSE ticker symbol, BMR, and a new tagline, Discover here™. Karen Sztraicher is promoted to Executive Vice President, Asset Management Jonathan Klassen is promoted to Senior Vice President, General Counsel and Secretary.